… 26 patients received this concomitant treatment without any … that concomitant treatment with
perhexiline and amiodarone may be … of plasma perhexiline concentrations to guide therapy. …

… with potentially interacting drugs (such as amiodarone, 25 … ) were not contraindications to
perhexiline therapy at entry. … details regarding concomitant CYP2D6 inhibitor therapy, this study …

… increased significantly by perhexiline therapy, with concomitant and marked amelioration …
case for the development of agents with less potential toxicity than amiodarone and perhexiline…

… report here our initial experience with perhexiline treatment … in this group of patients over
the first three months of therapy. … evidence of concomitant coronary artery disease. In addition, …

… Exposure to class III antiarrhythmic drugs was 4.0% in cases and 1.5% in controls, aOR =
3.6 (95% CI: 1.6–8.4). Associations with exposure to dronedarone and amiodarone were …

… • Current treatment with perhexiline or previous adverse reaction to perhexiline at therapeutic
… of recurrent hypoglycemia• Concomitant use of amiodarone, ranolazine or trimetazidine• …

… documented with amiodarone.[61] … concomitant plasma perhexiline concentrations ranging
between 720 and 2680 μg/L. Subsequently, another group of 22 similar patients were treated …

… Each JACC Patient Care Pathway is an immersive, multimedia case report depicting the …
than twice the upper limit of normal; concomitant use of amiodarone, quinidine, haloperidol, or …

… Any concomitant disease, condition, or treatment that could interfere with the conduct of the
study, or that would, in the opinion of the investigator or sponsor, pose an unacceptable risk …

… for such therapies (for example because of concomitant severe systolic heart failure) and
by the … of the anti-ischaemic effects of perhexiline and amiodarone. However, excessive or …